Incyte (INCY) stock Forecast for 2021 – 2025

Incyte (INCY) stock Forecast for 2022 – 2026

Last update: November 27, 2022 (06:06)

Sector: Healthcare

The share price of Incyte Corp. (INCY) now

What analysts predict: $87

52-week high/low: $84.86 / $62.3

50/200 Day Moving Average: $71.45 / $74.02

This figure corresponds to the average price over the previous 50/200 days. For Incyte stocks, the 50-day moving average is the support level today.

For Incyte stocks, the 200-day moving average is the support level today.

Are you interested in Incyte Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Incyte stock price in 2022, 2023, 2024, 2025, 2026. How much will one Incyte share be worth in 2022 - 2026?

When should I take profit in Incyte stock? When should I record a loss on Incyte stock? What are analysts' forecasts for Incyte stock? What is the future of Incyte stock? We forecast Incyte stock performance using neural networks based on historical data on Incyte stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Incyte stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Incyte shares. This happens once a day.




Historical and forecast chart of Incyte stock

The chart below shows the historical price of Incyte stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Incyte stock price can be found in the table below.

Long-term forecasts by years.

Incyte daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 29 80.88 80.30 81.56 1.57
Nov 30 81.53 79.75 82.05 2.88
Dec 01 81.93 80.13 82.91 3.47
Dec 02 82.17 81.01 83.13 2.62
Dec 03 84.02 82.48 84.73 2.72
Dec 04 84.58 83.66 86.55 3.46
Dec 05 83.86 81.98 85.80 4.67
Dec 06 83.31 81.99 85.16 3.87
Dec 07 83.86 82.58 85.27 3.26
Dec 08 82.90 82.06 84.00 2.36
Dec 09 82.41 81.86 83.25 1.69
Dec 10 82.48 81.67 83.89 2.73
Dec 11 84.86 83.46 86.13 3.20
Dec 12 86.54 85.19 87.89 3.17
Dec 13 87.97 86.88 89.73 3.28
Dec 14 89.07 87.44 90.49 3.48
Dec 15 90.86 89.28 92.06 3.11
Dec 16 90.75 89.07 92.17 3.48
Dec 17 88.22 86.13 89.39 3.78
Dec 18 87.03 85.54 88.52 3.48
Dec 19 85.88 83.82 87.76 4.70
Dec 20 85.24 84.16 87.00 3.37
Dec 21 87.54 86.25 89.14 3.35
Dec 22 89.54 88.78 90.72 2.18
Dec 23 89.72 88.00 91.64 4.13
Dec 24 90.77 89.60 92.54 3.28
Dec 25 88.24 86.26 90.17 4.54
Dec 26 89.27 88.04 90.53 2.83
Dec 27 87.59 86.51 89.40 3.34
Dec 28 87.09 85.10 88.50 3.99

Incyte Daily Price Targets


Incyte Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $80.88.
Positive dynamics for Incyte shares will prevail with possible volatility of 1.547%.
Pessimistic target level: 80.30
Optimistic target level: 81.56

Incyte Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $81.53.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.802%.
Pessimistic target level: 79.75
Optimistic target level: 82.05

Incyte Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $81.93.
Positive dynamics for Incyte shares will prevail with possible volatility of 3.350%.
Pessimistic target level: 80.13
Optimistic target level: 82.91

Incyte Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $82.17.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.550%.
Pessimistic target level: 81.01
Optimistic target level: 83.13

Incyte Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $84.02.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.648%.
Pessimistic target level: 82.48
Optimistic target level: 84.73

Incyte Stock Forecast 12-04-2022.

Forecast target price for 12-04-2022: $84.58.
Positive dynamics for Incyte shares will prevail with possible volatility of 3.342%.
Pessimistic target level: 83.66
Optimistic target level: 86.55

INCY (INCY) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 77.80 74.37 83.12 10.53

Incyte forecast for this year


Incyte Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $77.7985. Pessimistic: $74.37. Optimistic: $83.12



Incyte (INCY) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 76.61 73.44 78.06 5.92
Feb 74.06 72.72 75.46 3.62
Mar 70.66 66.78 73.52 9.17
Apr 72.69 69.29 75.51 8.23
May 78.58 73.21 83.96 12.80
Jun 84.59 81.85 87.03 5.95
Jul 80.94 77.88 85.45 8.87
Aug 78.68 73.72 82.36 10.49
Sep 85.55 81.55 88.94 8.31
Oct 89.24 86.27 91.09 5.29
Nov 85.39 80.32 89.23 9.99
Dec 87.16 81.20 89.43 9.21

Incyte (INCY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 83.94 82.35 86.06 4.30
Feb 83.86 79.64 86.81 8.26
Mar 80.09 78.22 82.25 4.91
Apr 81.82 80.27 85.21 5.79
May 85.50 80.96 90.89 10.92
Jun 82.19 76.79 84.78 9.42
Jul 82.34 78.64 86.94 9.55
Aug 81.97 76.66 85.29 10.12
Sep 80.50 75.93 82.89 8.39
Oct 77.24 72.02 80.71 10.77
Nov 81.96 79.45 85.50 7.07
Dec 88.97 82.80 94.10 12.00

Incyte (INCY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 94.10 88.42 96.47 8.34
Feb 98.92 91.89 105.60 12.98
Mar 92.78 89.19 99.04 9.95
Apr 91.19 89.06 94.97 6.22
May 91.19 88.73 93.90 5.51
Jun 94.15 88.81 98.38 9.73
Jul 102.20 98.43 105.14 6.39
Aug 98.15 92.76 101.07 8.22
Sep 97.71 91.82 100.08 8.26
Oct 105.18 99.31 107.83 7.90
Nov 110.96 108.36 112.96 4.07
Dec 116.55 109.10 119.17 8.45

Incyte (INCY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 122.32 118.58 128.92 8.03
Feb 122.43 115.49 127.94 9.73
Mar 119.01 113.77 122.87 7.41
Apr 120.51 112.27 127.89 12.21
May 118.89 110.75 122.95 9.92
Jun 119.10 115.46 125.64 8.11
Jul 122.42 119.56 126.28 5.32
Aug 124.85 116.08 127.54 8.99
Sep 120.91 114.93 129.08 10.96
Oct 116.67 108.48 122.24 11.25
Nov 123.29 117.40 129.39 9.26
Dec 117.74 113.39 120.17 5.64

Incyte information and performance

Incyte Corp is an American pharmaceutical company. The company was founded in Palo Alto, California in 1991 and became famous in 1993. Incyte has one drug, Jakafi, which has been approved by the US Food and Drug Administration (FDA) and has been prescribed to patients in the United States.

www.incyte.com

Incyte Address

1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US

Market Capitalization: 17 230 688 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 678 478 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 19.66

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.564

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 3.94

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.39
Quarterly Revenue Growth YOY: 0.013
Trailing PE: 19.66

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 17.33

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.326

Enterprise Value (EV) /Revenue

EV To EBITDA: 22.66

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 222475000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.